Realizing our “Triple-A Mandate”
Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA) […]
Featured News
Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment
19 December 2022: Viatris, a global healthcare company, MedAccess, and TB Alliance have announced a new agreement to reduce the
New Study: Recently Approved Drug-Resistant TB Treatments Can Save National Governments up to US$740 Million Annually
PRETORIA (16 November, 2022)—A new study published in PLOS Global Public Health found that the BPaLM/BPaL treatment regimen that will
Drug-Resistant TB Trial Results Published in New England Journal of Medicine
Results of ZeNix Trial Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB Can Be Maintained with Reduced Dosing of
TB Alliance Statement on New World Health Organization Rapid Communication on Key Changes to the Treatment of Drug-Resistant Tuberculosis
New Guidelines Have Potential to Transform the TB Treatment Landscape with Six-Month Standard PRETORIA (3 May 2022)—TB Alliance applauds today’s
Advancing the Treatment of Drug-Resistant Tuberculosis this World TB Day
Imagining a TB-free world amidst resurgence during COVID-19 pandemic NEW YORK (March 24, 2022)—The world continues to battle against two
At United Nations High Level Meeting, World Leaders Commit to Ending TB
Unfortunately, the recent history of the tuberculosis (TB) pandemic has in large part been defined by neglect—inadequate funding for research
Amid Global Pandemic, TB Treatment Innovation Advances at an Unprecedented Pace
PRETORIA (24 March 2021)—On World TB Day, as society reflects on how COVID-19 became the world’s most lethal infection in the
TB Alliance is Honored to Accept the Prix Galien Award for Best Pharmaceutical Agent
NEW YORK (October 30, 2020)—At the Prix Galien Awards Ceremony on Thursday, October 29, The Galien Foundation named pretomanid the
With Progress against TB in Jeopardy, New and Improved Tools Are More Urgent than Ever
NEW YORK (October 14, 2020)—The World Health Organization’s Global Tuberculosis (TB) Report 2020 confirms that efforts to track and treat TB